The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with鈥�
- Investigator
- John A Ligon
- Ages
- 2 Years - 40 Years
- Sexes
- All